Researchers have developed a new method for preparing mesenchymal stem cells (MSCs) that not only leads to the production of more native stem cells, but also labels them with a FDA approved iron-oxide nanoparticle (Ferumoxytol). The technology could allow researchers to track the cells in vivo using magnetic resonance imaging (MRI) during preclinical and clinical trials. Read more at Carnegie Mellon University News.
Bio-mimicry method developed for preparing, labeling stem cells
May 19, 2016